Stock chart
Analyses on Identi Health (4)
- March 31, 2026March 31, 2026
- Follow-up
Identi Healthcare: Gross-Margin Quality, Inventory, and the Cash-Flow Gap
Identi's 2025 gross margin did improve, but the quality of that improvement is mixed: services genuinely got stronger, while the product layer also benefited from cost deferral through inventory build and the full reported year was helped further by the Innovation Authority acco…
- Follow-up
Identi Healthcare: Related-Party Economics and the Real Funding Flexibility
Identi ended 2025 with a balance sheet that looks cleaner on the surface, but its real flexibility still depends materially on the controller's ecosystem: equipment procurement, office infrastructure, and marginal financing continue to run through related parties.
- Follow-up
Identi Healthcare: Is the U.S. Funnel Deep Enough to Change the Numbers?
Identi's U.S. funnel now looks like a real commercial funnel rather than a loose collection of pilots, but until the Mayo Clinic and OrthoVirginia steps convert into broader deployments and recurring revenue, the change still belongs to the proof stage rather than to the reporte…
Identi Healthcare 2025: Margin Improved, but the Proof Year Is Still Ahead
Identi enters 2026 with a better revenue mix and a stronger gross-profit profile, but this is still a proof-year thesis: U.S. revenue is small, operating cash burn remains heavy, and the real step-up depends on converting orders and pilots into broader rollouts.
